Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5′-segment of the upstream regulatory region (URR)-Reference-Cited by-同舟云学术

Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5′-segment of the upstream regulatory region (URR)

Published:2002-08 Issue:2 Volume:55 Page:331-339
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Arany Istvan,Grattendick Kenneth G,Tyring Stephen K

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference36 articles.

1. Antisense proenkephalin cDNA transfection decreases opioid binding in NG 108-15 cells;Arany;Brain Res. Mol. Brain Res.,1992

2. A key DNA-protein interaction determines the function of the 5′URR enhancer in human papillomavirus type 11;Auborn;Virology,1991

3. Response to IL-6 of HPV-18 cervical carcinoma cell lines;Bauknecht;Virology,1999

4. Induction of IL-10 synthesis by human keratinocytes through CD23 ligation: a cyclic adenosine 3′,5′-monophosphate-dependent mechanism;Becherel;J. Immunol.,1997

5. Transcriptional control and cell type specificity of HPV gene expression;Bernard;Arch. Dermatol.,1994

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance;Non-coding RNA Research;2024-02

2. Physical interaction between STAT3 and AP1 in cervical carcinogenesis: Implications in HPV transcription control;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2023-12

3. Immune microenvironment of cervical cancer and the role of IL-2 in tumor promotion;Cytokine;2023-10

4. Interactions between vaginal local cytokine IL-2 and high-risk human papillomavirus infection with cervical intraepithelial neoplasia in a Chinese population-based study;Frontiers in Cellular and Infection Microbiology;2023-05-15

5. Implications and Emerging Therapeutic Avenues of Inflammatory Response in HPV+ Head and Neck Squamous Cell Carcinoma;Cancers;2022-11-02